Correlation Between Shenzhen Bioeasy and Sinochem International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Bioeasy and Sinochem International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Bioeasy and Sinochem International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Bioeasy Biotechnology and Sinochem International Corp, you can compare the effects of market volatilities on Shenzhen Bioeasy and Sinochem International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Bioeasy with a short position of Sinochem International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Bioeasy and Sinochem International.

Diversification Opportunities for Shenzhen Bioeasy and Sinochem International

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Shenzhen and Sinochem is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Bioeasy Biotechnology and Sinochem International Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinochem International and Shenzhen Bioeasy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Bioeasy Biotechnology are associated (or correlated) with Sinochem International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinochem International has no effect on the direction of Shenzhen Bioeasy i.e., Shenzhen Bioeasy and Sinochem International go up and down completely randomly.

Pair Corralation between Shenzhen Bioeasy and Sinochem International

Assuming the 90 days trading horizon Shenzhen Bioeasy Biotechnology is expected to generate 1.97 times more return on investment than Sinochem International. However, Shenzhen Bioeasy is 1.97 times more volatile than Sinochem International Corp. It trades about 0.0 of its potential returns per unit of risk. Sinochem International Corp is currently generating about 0.0 per unit of risk. If you would invest  1,218  in Shenzhen Bioeasy Biotechnology on September 5, 2024 and sell it today you would lose (226.00) from holding Shenzhen Bioeasy Biotechnology or give up 18.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Shenzhen Bioeasy Biotechnology  vs.  Sinochem International Corp

 Performance 
       Timeline  
Shenzhen Bioeasy Bio 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point.
Sinochem International 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sinochem International Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sinochem International sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Bioeasy and Sinochem International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Bioeasy and Sinochem International

The main advantage of trading using opposite Shenzhen Bioeasy and Sinochem International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Bioeasy position performs unexpectedly, Sinochem International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinochem International will offset losses from the drop in Sinochem International's long position.
The idea behind Shenzhen Bioeasy Biotechnology and Sinochem International Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years